Secukinumab as biological treatment for psoriatic arthritis in real clinical practice José A. Pinto Tasende; Francisco J. Maceiras Pan; José A. Mosquera Martínez; Luis Fernández Dominguez; Blanca Correa Rey; Carlos García Porrúa;

Patients with spondyloarthritis including psoriatic arthritis: Current needs, impact, and perspective Estíbaliz Loza; Pedro Plazuelo; Ceade;

A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis Alberto Jiménez-Morales; Rafael Cáliz; Susana Aceituno; Miriam Prades; Carles Blanch;